Tele: 561.316.3330
Breaking Medical Device News

Wednesday, October 20, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeACQUISITIONS and MERGERSProbo Medical Acquires SonoDepot

Probo Medical Acquires SonoDepot

MARKET REPORTS

Global $45 Billion Endoscopy Market Insights & Forecasts to 2025

The global endoscopy market is predicted to reach US$45.28 billion in 2025, growing, at a CAGR of 7.50%, for the duration spanning 2021-2025.

Global Remote Monitoring Devices Market Research Report (2021 to 2026)

Global Remote Monitoring Devices Market size was estimated at USD 1,035.35 million in 2020, is expected to reach USD 1,170.22 million in 2021.

Research Efforts Fuel the Future of Global Obstructive Lung Disease Management Markets – ResearchAndMarkets.com

The "Global Obstructive Lung Disease Management Research Report" report has been added.

Global Electrophysiology Market (2021 to 2026) – Growth, Trends , COVID-19 Impact and Forecasts – ResearchAndMarkets.com

The Electrophysiology Market is expected to register a CAGR of 8.5% during the forecast period.

April 19, 2021

Probo Medical is a leading global provider of medical imaging equipment, parts, repair and service. Terms of the transaction were not disclosed.

Probo Medical notes SonoDepot, founded in 1985, is a St. Cloud, Florida-based third-party service, maintenance, and repair organization with deep specialization in ultrasound equipment. SonoDepot’s team of field service engineers have a long history of supporting hospitals, physician offices and imaging centers across the United States for their ultrasound maintenance, service and sales needs. SonoDepot, led today by Floyd McAuliffe and Jack McAuliffe, also offers ultrasound equipment leasing solutions to its customers.

“We are excited to welcome the SonoDepot team to Probo Medical,” said Michael Asmer, CEO of Probo Medical. “With their deep technical expertise across OEM models, the SonoDepot team has established themselves as one of the premier service and repair businesses in the ultrasound sector. Adding the SonoDepot field service engineers to Probo’s existing service footprint extends Probo as a coast-to-coast third-party service provider and we’re excited to support SonoDepot’s customers with the added-resources of Probo.”

SonoDepot President, Floyd McAuliffe, said, “Partnering with Probo provides SonoDepot with a proven platform and management team that will allow the business to continue to thrive into the future. With Probo’s vast inventory of ultrasound parts, probes and systems, we are excited for the positive impacts this will have on our ability to exceed our customers’ expectations. We would like to express our gratitude to the thousands of sonographers that we’ve had the joy of serving for nearly 40 years, and to our employees that have taken SonoDepot to this level.”

Jack McAuliffe, SonoDepot CEO, added, “We have known the Probo team for many years and see deep alignment, not only with respect to our business interests, but, more importantly, in a common culture that puts the customer and our employees at the center of what we do. We feel very fortunate to serve our customers and to have built the strong relationships we have with our customers over the many years of supporting their ultrasound needs. Our team is enthusiastic to continue that as part of the Probo family.”

Probo Medical is backed by Varsity Healthcare Partners, a lower middle-market private equity investment firm focused on partnering with founders, entrepreneurs and management teams to build leading healthcare services companies.

spot_img

DON'T MISS

Children Achieve Time in Range Mirroring Well-controlled Adults for the 1st Time in Real-world Study of the MiniMed™ 780G System

"These results are extremely encouraging. Glycemic control has been much harder to achieve in children due to unpredictable factors common in this age group, including physical growth and development, hormonal changes and active lifestyles.

Aethlon Medical Announces Peer-Reviewed Publication of Two Case Studies of Critically Ill COVID-19 Patients Treated with the Hemopurifier®

The publication documents two critically ill COVID-19 patients receiving a combined total of nine, six-hour Hemopurifier® treatment sessions.

Koya Medical Presents Positive Interim Data from Randomized Trial Comparing its Dayspring Lymphedema Treatment to Pneumatic Compression

For people with lymphedema, movement is important from both a clinical perspective and a quality-of-life perspective. These data illustrate the Dayspring treatment’s ability to provide that essential movement while still delivering the clinical outcomes we need from compression therapy.

Our Sister Publication: Biotechnology News Magazine

By using this website you agree to accept Medical Device News Magazine Privacy Policy